Previous close | 10.58 |
Open | 10.25 |
Bid | 9.80 x 1200 |
Ask | 9.85 x 800 |
Day's range | 9.55 - 10.25 |
52-week range | 9.55 - 18.43 |
Volume | |
Avg. volume | 20,993 |
Market cap | 89.003M |
Beta (5Y monthly) | 1.88 |
PE ratio (TTM) | 19.29 |
EPS (TTM) | 0.51 |
Earnings date | 02 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 30 Mar 2020 |
1y target est | 17.25 |
SAN CLEMENTE, Calif., May 04, 2022--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2022. Key highlights include:
ACRES Commercial Realty Corp. ( NYSE:ACR ) shareholders should be happy to see the share price up 20% in the last...